Florence Nightingale School of Nursing and Midwifery, King's College London, , London, UK.
Arch Dis Child Fetal Neonatal Ed. 2014 May;99(3):F245-9. doi: 10.1136/archdischild-2013-305191. Epub 2014 Feb 19.
Preterm birth is a major global public health issue due to its prevalence, impact upon morbidity and mortality, and subsequent cost implications. Yet, policy analysis has not been undertaken to understand the different approaches across Europe to treatment decisions, and parental involvement in these decisions.
A European survey and national guidance documentation analysis was undertaken with national neonatal or paediatric societies in Europe, exploring treatment decisions and parental involvement in decision-making for babies born at 22 to 25 completed weeks of gestation.
Responses were obtained from 19 European countries of 28 contacted. At 25 weeks of gestation there was universal initiation of active care at birth. At 24 weeks policy varied from initiating interventions (9), interventions dependent upon infant condition (8) and resuscitation restrictions (2). At 23 weeks and below, policy varied from no active intervention (7), individualised decision-making (8), parental permission required (3) and universal initiation of interventions (1). There were significant variations in the involvement of parents in the development of policy and in 16 countries the final decision regarding interventions rested with the attending doctor.
There was little consensus as to how active intervention after birth at 22 to 25 weeks of gestation is managed, nor were parents included in the development of policy in many countries. At extremely low gestational ages, the criteria for or against active intervention at birth vary widely between different health systems in Europe.
早产是一个全球性的主要公共卫生问题,因为它的普遍性、对发病率和死亡率的影响,以及随后的成本影响。然而,尚未进行政策分析,以了解欧洲在治疗决策方面的不同方法,以及父母在这些决策中的参与度。
对欧洲的一项调查和国家指导文件分析,涉及欧洲的国家新生儿或儿科协会,探索了在妊娠 22 至 25 周完成时出生的婴儿的治疗决策和父母在决策中的参与度。
在联系的 28 个国家中,有 19 个欧洲国家作出了回应。在 25 周时,普遍开始在出生时进行积极治疗。在 24 周时,政策从开始干预(9 个国家)、干预取决于婴儿状况(8 个国家)和复苏限制(2 个国家)。在 23 周及以下,政策从没有积极干预(7 个国家)、个体化决策(8 个国家)、需要父母同意(3 个国家)和普遍开始干预(1 个国家)。父母在政策制定中的参与度以及在 16 个国家中,干预的最终决策权取决于主治医生,这两方面都存在显著差异。
对于在妊娠 22 至 25 周出生后如何进行积极干预,几乎没有共识,而且在许多国家,父母都没有参与政策的制定。在极低的胎龄,欧洲不同的卫生系统之间在出生时进行积极干预的标准或依据存在很大差异。